Cargando…

Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus

BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Li-Heng, Huang, Yao, Zhou, Jia, Liang, Xing-Huan, Xian, Jing, Li, Li, Qin, Ying-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381313/
https://www.ncbi.nlm.nih.gov/pubmed/28345543
http://dx.doi.org/10.4103/0366-6999.202739
_version_ 1782519914972577792
author Meng, Li-Heng
Huang, Yao
Zhou, Jia
Liang, Xing-Huan
Xian, Jing
Li, Li
Qin, Ying-Fen
author_facet Meng, Li-Heng
Huang, Yao
Zhou, Jia
Liang, Xing-Huan
Xian, Jing
Li, Li
Qin, Ying-Fen
author_sort Meng, Li-Heng
collection PubMed
description BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients with hyperthyroidism were divided into hyperthyroidism with normal glucose tolerance (TNGT), hyperthyroidism with impaired glucose regulation (TIGR), and diabetes (TDM) groups. Furthermore, 96 patients without hyperthyroidism were recruited as control groups (normal glucose tolerance [NGT], impaired glucose regulation [IGR], and T2DM). The following parameters were evaluated: homeostasis model assessment (HOMA)-IR, HOMA-β, modified β-cell function index (MBCI), peak insulin/fasting insulin (I(P)/I(0)), AUC(ins-OGTT), and AUC(ins-OGTT)/AUC(glu-OGTT) from the oral glucose tolerance test (OGTT) insulin release test were utilized to assess the second-phase insulin secretion, while the I(P)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) from the intravenous glucose tolerance test (IVGTT) insulin release test were used to assess the first-phase insulin secretion. RESULTS: In the OGTT, the HOMA-β values of the TNGT and TDM groups were higher than those of the NGT and T2DM groups (all P < 0.05). In the hyperthyroidism groups, the MBCI of the TDM group was lower than that of the TNGT and TIGR groups (all P < 0.05). Among the control groups, the MBCI values of the IGR and T2DM groups were lower than that of the normal glucose tolerance (NGT) group (all P < 0.05). In the IVGTT, insulin secretion peaked for all groups at 2–4 min, except for the T2DM group, which showed a low plateau and no secretion peak. The I(P) values of the TNGT, TIGR, and TDM groups were higher than those of the NGT, IGR, and T2DM groups (all P < 0.05). The I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the TDM group were higher than those of the T2DM group but were lower than those of the TNGT, TIGR, NGR, and IGR groups (all P < 0.05). Compared with the other five groups, the I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the T2DM group were significantly decreased (all P < 0.05). The I(p)/I(0) and AUC(ins-IVGTT) values of the TNGT group were higher than those of the NGT group (all P < 0.05). CONCLUSIONS: β-cell function in TDM patients is superior to that in T2DM patients. First-phase insulin secretion could be used as an early diagnostic marker to differentiate TDM and T2DM.
format Online
Article
Text
id pubmed-5381313
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53813132017-04-26 Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus Meng, Li-Heng Huang, Yao Zhou, Jia Liang, Xing-Huan Xian, Jing Li, Li Qin, Ying-Fen Chin Med J (Engl) Original Article BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients with hyperthyroidism were divided into hyperthyroidism with normal glucose tolerance (TNGT), hyperthyroidism with impaired glucose regulation (TIGR), and diabetes (TDM) groups. Furthermore, 96 patients without hyperthyroidism were recruited as control groups (normal glucose tolerance [NGT], impaired glucose regulation [IGR], and T2DM). The following parameters were evaluated: homeostasis model assessment (HOMA)-IR, HOMA-β, modified β-cell function index (MBCI), peak insulin/fasting insulin (I(P)/I(0)), AUC(ins-OGTT), and AUC(ins-OGTT)/AUC(glu-OGTT) from the oral glucose tolerance test (OGTT) insulin release test were utilized to assess the second-phase insulin secretion, while the I(P)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) from the intravenous glucose tolerance test (IVGTT) insulin release test were used to assess the first-phase insulin secretion. RESULTS: In the OGTT, the HOMA-β values of the TNGT and TDM groups were higher than those of the NGT and T2DM groups (all P < 0.05). In the hyperthyroidism groups, the MBCI of the TDM group was lower than that of the TNGT and TIGR groups (all P < 0.05). Among the control groups, the MBCI values of the IGR and T2DM groups were lower than that of the normal glucose tolerance (NGT) group (all P < 0.05). In the IVGTT, insulin secretion peaked for all groups at 2–4 min, except for the T2DM group, which showed a low plateau and no secretion peak. The I(P) values of the TNGT, TIGR, and TDM groups were higher than those of the NGT, IGR, and T2DM groups (all P < 0.05). The I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the TDM group were higher than those of the T2DM group but were lower than those of the TNGT, TIGR, NGR, and IGR groups (all P < 0.05). Compared with the other five groups, the I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the T2DM group were significantly decreased (all P < 0.05). The I(p)/I(0) and AUC(ins-IVGTT) values of the TNGT group were higher than those of the NGT group (all P < 0.05). CONCLUSIONS: β-cell function in TDM patients is superior to that in T2DM patients. First-phase insulin secretion could be used as an early diagnostic marker to differentiate TDM and T2DM. Medknow Publications & Media Pvt Ltd 2017-04-05 /pmc/articles/PMC5381313/ /pubmed/28345543 http://dx.doi.org/10.4103/0366-6999.202739 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Meng, Li-Heng
Huang, Yao
Zhou, Jia
Liang, Xing-Huan
Xian, Jing
Li, Li
Qin, Ying-Fen
Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title_full Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title_fullStr Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title_full_unstemmed Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title_short Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
title_sort use of first-phase insulin secretion in early diagnosis of thyroid diabetes and type 2 diabetes mellitus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381313/
https://www.ncbi.nlm.nih.gov/pubmed/28345543
http://dx.doi.org/10.4103/0366-6999.202739
work_keys_str_mv AT mengliheng useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT huangyao useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT zhoujia useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT liangxinghuan useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT xianjing useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT lili useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus
AT qinyingfen useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus